Protekt Therapeutics is a drug development company aiming to develop inhibitors of PKR for various diseases
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Ness Ziona
State: HaMerkaz
Zip:
Country: Israel
ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2019 | Venture Round | 7 | $4.1M |
Bukwang Pharmaceutical Co Fonds de solidarité FTQ FutuRx Johnson &a; Johnson Innovation – JJDC OrbiMed RMGP Biopharma Investment Fund Takeda Ventures Bukwang Pharmaceutical Co Fonds de solidarité FTQ FutuRx Johnson &a; Johnson Innovation – JJDC OrbiMed RMGP Biopharma Investment Fund Takeda Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|